IQVIA Clinical Trials Localization

Accelerate patient access to innovation

Every day a clinical trial is delayed is a day patients wait longer for access to potentially life-changing therapies.

Yet global studies continue to face challenges caused by language barriers, fragmented translation processes, inconsistent terminology and complex multinational documentation requirements. These challenges slow study start-up, delay site activation, create operational inefficiencies and introduce unnecessary risk into clinical development programs.

IQVIA helps sponsors, CROs and clinical operations teams transform clinical translations from a study bottleneck into a performance accelerator. Through AI-enabled clinical translation, expert review workflows and life sciences-specific governance, we help organizations execute multilingual clinical trials with greater speed, consistency and confidence.

CONTACT US
Solutions IQVIA Technologies Language Solutions Language Solutions for Clinical Operations
background accent graphic

CLINCAL TRANSLATIONS EXPERTISE

Clinical translation services built for global trial execution

Clinical trials generate thousands of documents that must be translated, reviewed, updated and deployed across countries, sites and stakeholders.

IQVIA provides clinical translation services specifically designed for clinical development environments, helping organizations manage multilingual trial content throughout the study lifecycle. Unlike general translation providers, our approach is purpose-built around the operational realities of clinical research.

Whether supporting study start-up, patient recruitment, decentralized trials or ongoing study operations, we help clinical teams move faster while maintaining consistency, transparency and compliance across global programs.

25%

Reducing cost of clinical translation Project delivered for a top pharma client

300%

more stringent quality indices compared to legacy language models

14,000

Informed Consent Forms and Protocols Translated in 2024

SOLUTIONS BUILT FOR SPEED

Reduce friction across every stage of the trial lifecycle

Language impacts far more than document translation.

It influences site readiness, patient comprehension, consent quality, recruitment effectiveness, stakeholder alignment and ongoing study execution. When language processes are fragmented, delays accumulate throughout the trial lifecycle.

IQVIA helps clinical teams reduce these delays through a unified approach to clinical translations, localization and multilingual content governance that supports:

Our difference

Human expertise, Healthcare-grade AI, Clinical governance

No two clinical content types carry the same level of risk.

IQVIA routes content through the appropriate combination of AI-powered translation, expert linguistic review and governance controls based on content criticality, intended audience and regulatory requirements. This allows organizations to accelerate trial execution while maintaining appropriate oversight and quality.

By combining healthcare-grade AI, clinical translation expertise and workflow governance, we help organizations scale multilingual trial operations without increasing complexity.

GET IN TOUCH

Clinical content we support

From study start-up through ongoing trial operations, IQVIA provides specialized clinical translation services and multilingual content management designed to reduce delays, improve patient participation and support consistent global execution across every stage of the trial lifecycle.

CLINICAL TRANSLATIONS

The positive business impact

Faster study startup

Reduce delays associated with multilingual content preparation, review cycles and site activation activities..

Better patient participation

Improve comprehension, cultural relevance and usability of patient-facing materials used throughout the study journey.

Lower operational friction

Reduce vendor hand-offs, rework and workflow fragmentation while improving transparency and control.

Accelerated patient access

Help innovative therapies reach eligible patients faster by enabling more efficient global trial execution.

Stronger compliance confidence

Support consistent, audit-ready multilingual trial documentation across countries and sites.

Why chose IQVIA for clinical translations?

Most translation providers translate documents.

IQVIA helps accelerate clinical trials.

Our teams understand the intersection of clinical operations, patient engagement, regulatory requirements and global trial execution. Combined with AI-enabled workflows and deep life sciences expertise, this allows us to support multilingual clinical studies from study design through execution and beyond.

Because language should not be the reason a trial starts late, a site activates slowly or a patient fails to engage.

Why us
Trusted language solutions, for the speed of science

IQVIA Global Clinical Trial Enablement helps life sciences organizations execute multilingual clinical trials more efficiently through specialized clinical translation services, healthcare-grade AI and deep clinical expertise.

From protocol translation and informed consent forms to patient recruitment materials and decentralized trial content, we help clinical teams reduce friction, improve participation and accelerate patient access to innovation.

Contact us

Our Latest Thinking

Fact Sheet
IQVIA Integrated COA Solutions: Licensing, Linguistic Validation, and eCOA Implementation
Fact Sheet
IQVIA Language Solutions: Accelerating Clinical Trials Operations
White Paper
Bridging the Language Gap
Case Study
Ensuring Timely and Accurate EU-CTR Submissions
Case Study
Translating Clinical Information Faster Whilst Ensuring Quality
Case Study
Science First: IQVIA Linguistic Validation Delivers a Complex Cognitive Battery Project on a Tight Timeline
Prev
Next
Contact Us